nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.303	1	CbGbCtD
Nortriptyline—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0258	0.119	CbGeAlD
Nortriptyline—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0437	CcSEcCtD
Nortriptyline—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0418	CcSEcCtD
Nortriptyline—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0298	CcSEcCtD
Nortriptyline—Mania—Riluzole—amyotrophic lateral sclerosis	0.0116	0.029	CcSEcCtD
Nortriptyline—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0112	0.028	CcSEcCtD
Nortriptyline—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.011	0.0276	CcSEcCtD
Nortriptyline—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0257	CcSEcCtD
Nortriptyline—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00983	0.0245	CcSEcCtD
Nortriptyline—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00911	0.0228	CcSEcCtD
Nortriptyline—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00861	0.0215	CcSEcCtD
Nortriptyline—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00845	0.0211	CcSEcCtD
Nortriptyline—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00794	0.0198	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00702	0.0175	CcSEcCtD
Nortriptyline—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00686	0.0171	CcSEcCtD
Nortriptyline—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00672	0.0311	CbGeAlD
Nortriptyline—HTR2A—pons—amyotrophic lateral sclerosis	0.00664	0.0307	CbGeAlD
Nortriptyline—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00662	0.0165	CcSEcCtD
Nortriptyline—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00637	0.0159	CcSEcCtD
Nortriptyline—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00609	0.0152	CcSEcCtD
Nortriptyline—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00599	0.015	CcSEcCtD
Nortriptyline—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0146	CcSEcCtD
Nortriptyline—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00577	0.0144	CcSEcCtD
Nortriptyline—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00573	0.0265	CbGeAlD
Nortriptyline—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00567	0.0262	CbGeAlD
Nortriptyline—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00561	0.014	CcSEcCtD
Nortriptyline—DRD2—nerve—amyotrophic lateral sclerosis	0.00522	0.0242	CbGeAlD
Nortriptyline—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00504	0.0126	CcSEcCtD
Nortriptyline—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0049	0.0122	CcSEcCtD
Nortriptyline—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00489	0.0122	CcSEcCtD
Nortriptyline—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00488	0.0225	CbGeAlD
Nortriptyline—HTR2A—appendage—amyotrophic lateral sclerosis	0.00486	0.0225	CbGeAlD
Nortriptyline—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00483	0.0121	CcSEcCtD
Nortriptyline—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0048	0.012	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00466	0.0116	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00464	0.0116	CcSEcCtD
Nortriptyline—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00464	0.0116	CcSEcCtD
Nortriptyline—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00461	0.0115	CcSEcCtD
Nortriptyline—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00461	0.0115	CcSEcCtD
Nortriptyline—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00453	0.0113	CcSEcCtD
Nortriptyline—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00442	0.0204	CbGeAlD
Nortriptyline—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00441	0.011	CcSEcCtD
Nortriptyline—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00433	0.02	CbGeAlD
Nortriptyline—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0106	CcSEcCtD
Nortriptyline—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00422	0.0105	CcSEcCtD
Nortriptyline—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00422	0.0105	CcSEcCtD
Nortriptyline—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0104	CcSEcCtD
Nortriptyline—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00399	0.0185	CbGeAlD
Nortriptyline—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00397	0.0099	CcSEcCtD
Nortriptyline—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00391	0.0181	CbGeAlD
Nortriptyline—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00947	CcSEcCtD
Nortriptyline—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00937	CcSEcCtD
Nortriptyline—Tension—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00905	CcSEcCtD
Nortriptyline—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00903	CcSEcCtD
Nortriptyline—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00896	CcSEcCtD
Nortriptyline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00864	CcSEcCtD
Nortriptyline—HTR2A—nerve—amyotrophic lateral sclerosis	0.00345	0.0159	CbGeAlD
Nortriptyline—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00856	CcSEcCtD
Nortriptyline—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00848	CcSEcCtD
Nortriptyline—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00832	CcSEcCtD
Nortriptyline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00827	CcSEcCtD
Nortriptyline—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00826	CcSEcCtD
Nortriptyline—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00815	CcSEcCtD
Nortriptyline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00811	CcSEcCtD
Nortriptyline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00799	CcSEcCtD
Nortriptyline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00797	CcSEcCtD
Nortriptyline—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00783	CcSEcCtD
Nortriptyline—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00776	CcSEcCtD
Nortriptyline—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00768	CcSEcCtD
Nortriptyline—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00759	CcSEcCtD
Nortriptyline—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00753	CcSEcCtD
Nortriptyline—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00299	0.0138	CbGeAlD
Nortriptyline—Shock—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00741	CcSEcCtD
Nortriptyline—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00737	CcSEcCtD
Nortriptyline—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00295	0.0136	CbGeAlD
Nortriptyline—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00735	CcSEcCtD
Nortriptyline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00728	CcSEcCtD
Nortriptyline—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.00288	0.0133	CbGeAlD
Nortriptyline—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00718	CcSEcCtD
Nortriptyline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00704	CcSEcCtD
Nortriptyline—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.0028	0.0129	CbGeAlD
Nortriptyline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00681	CcSEcCtD
Nortriptyline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00676	CcSEcCtD
Nortriptyline—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00669	CcSEcCtD
Nortriptyline—HTR6—nervous system—amyotrophic lateral sclerosis	0.00267	0.0124	CbGeAlD
Nortriptyline—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00663	CcSEcCtD
Nortriptyline—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00655	CcSEcCtD
Nortriptyline—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00649	CcSEcCtD
Nortriptyline—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00258	0.0119	CbGeAlD
Nortriptyline—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00644	CcSEcCtD
Nortriptyline—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00257	0.0119	CbGeAlD
Nortriptyline—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00249	0.0062	CcSEcCtD
Nortriptyline—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00248	0.0115	CbGeAlD
Nortriptyline—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00246	0.0114	CbGeAlD
Nortriptyline—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00598	CcSEcCtD
Nortriptyline—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00595	CcSEcCtD
Nortriptyline—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00595	CcSEcCtD
Nortriptyline—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00235	0.0109	CbGeAlD
Nortriptyline—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00234	0.0108	CbGeAlD
Nortriptyline—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00229	0.0106	CbGeAlD
Nortriptyline—CHRM4—brain—amyotrophic lateral sclerosis	0.00228	0.0106	CbGeAlD
Nortriptyline—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00225	0.0104	CbGeAlD
Nortriptyline—DRD2—brainstem—amyotrophic lateral sclerosis	0.00224	0.0104	CbGeAlD
Nortriptyline—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00555	CcSEcCtD
Nortriptyline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0054	CcSEcCtD
Nortriptyline—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00533	CcSEcCtD
Nortriptyline—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00213	0.00986	CbGeAlD
Nortriptyline—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00209	0.00965	CbGeAlD
Nortriptyline—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00515	CcSEcCtD
Nortriptyline—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00206	0.00951	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00205	0.0095	CbGeAlD
Nortriptyline—HTR6—brain—amyotrophic lateral sclerosis	0.00204	0.00945	CbGeAlD
Nortriptyline—ORM1—spinal cord—amyotrophic lateral sclerosis	0.00204	0.00943	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00201	0.00929	CbGeAlD
Nortriptyline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00498	CcSEcCtD
Nortriptyline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00479	CcSEcCtD
Nortriptyline—Rash—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00475	CcSEcCtD
Nortriptyline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00474	CcSEcCtD
Nortriptyline—Headache—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00472	CcSEcCtD
Nortriptyline—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00183	0.00848	CbGeAlD
Nortriptyline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00447	CcSEcCtD
Nortriptyline—CHRM5—brain—amyotrophic lateral sclerosis	0.00179	0.00825	CbGeAlD
Nortriptyline—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00174	0.00804	CbGeAlD
Nortriptyline—ORM1—nervous system—amyotrophic lateral sclerosis	0.00172	0.00795	CbGeAlD
Nortriptyline—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00172	0.00793	CbGeAlD
Nortriptyline—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00166	0.00765	CbGeAlD
Nortriptyline—ADRA1B—brain—amyotrophic lateral sclerosis	0.00163	0.00754	CbGeAlD
Nortriptyline—HTR2A—embryo—amyotrophic lateral sclerosis	0.00161	0.00746	CbGeAlD
Nortriptyline—CHRM2—nervous system—amyotrophic lateral sclerosis	0.0016	0.00741	CbGeAlD
Nortriptyline—ADRA1D—brain—amyotrophic lateral sclerosis	0.0016	0.00737	CbGeAlD
Nortriptyline—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00155	0.00714	CbGeAlD
Nortriptyline—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00154	0.00713	CbGeAlD
Nortriptyline—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00154	0.00713	CbGeAlD
Nortriptyline—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00149	0.00688	CbGeAlD
Nortriptyline—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00148	0.00684	CbGeAlD
Nortriptyline—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00146	0.00677	CbGeAlD
Nortriptyline—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00146	0.00674	CbGeAlD
Nortriptyline—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00652	CbGeAlD
Nortriptyline—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.0014	0.00649	CbGeAlD
Nortriptyline—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00135	0.00623	CbGeAlD
Nortriptyline—CHRM3—nervous system—amyotrophic lateral sclerosis	0.00131	0.00604	CbGeAlD
Nortriptyline—HTR1A—nervous system—amyotrophic lateral sclerosis	0.0013	0.00601	CbGeAlD
Nortriptyline—Amitriptyline—SIGMAR1—amyotrophic lateral sclerosis	0.00129	0.591	CrCbGaD
Nortriptyline—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00129	0.00596	CbGeAlD
Nortriptyline—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00126	0.00581	CbGeAlD
Nortriptyline—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00579	CbGeAlD
Nortriptyline—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00124	0.00574	CbGeAlD
Nortriptyline—CHRM2—brain—amyotrophic lateral sclerosis	0.00123	0.00566	CbGeAlD
Nortriptyline—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00122	0.00566	CbGeAlD
Nortriptyline—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.0012	0.00554	CbGeAlD
Nortriptyline—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00119	0.00549	CbGeAlD
Nortriptyline—HTR2C—brain—amyotrophic lateral sclerosis	0.00118	0.00546	CbGeAlD
Nortriptyline—DRD2—nervous system—amyotrophic lateral sclerosis	0.00118	0.00543	CbGeAlD
Nortriptyline—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00115	0.00534	CbGeAlD
Nortriptyline—ALB—brain—amyotrophic lateral sclerosis	0.00115	0.00533	CbGeAlD
Nortriptyline—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00113	0.00523	CbGeAlD
Nortriptyline—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00113	0.00521	CbGeAlD
Nortriptyline—SLC6A4—brain—amyotrophic lateral sclerosis	0.00112	0.00518	CbGeAlD
Nortriptyline—CHRM1—brain—amyotrophic lateral sclerosis	0.00112	0.00516	CbGeAlD
Nortriptyline—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00111	0.00511	CbGeAlD
Nortriptyline—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00106	0.00489	CbGeAlD
Nortriptyline—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00103	0.00477	CbGeAlD
Nortriptyline—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.00102	0.00471	CbGeAlD
Nortriptyline—CHRM3—brain—amyotrophic lateral sclerosis	0.000998	0.00461	CbGeAlD
Nortriptyline—HTR1A—brain—amyotrophic lateral sclerosis	0.000994	0.00459	CbGeAlD
Nortriptyline—SLC6A2—brain—amyotrophic lateral sclerosis	0.000986	0.00456	CbGeAlD
Nortriptyline—HRH1—nervous system—amyotrophic lateral sclerosis	0.000928	0.00429	CbGeAlD
Nortriptyline—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00092	0.00425	CbGeAlD
Nortriptyline—ADRA1A—brain—amyotrophic lateral sclerosis	0.000916	0.00424	CbGeAlD
Nortriptyline—DRD2—brain—amyotrophic lateral sclerosis	0.000898	0.00415	CbGeAlD
Nortriptyline—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000893	0.00413	CbGeAlD
Nortriptyline—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.000892	0.409	CrCbGaD
Nortriptyline—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000892	0.00412	CbGeAlD
Nortriptyline—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000859	0.00397	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000859	0.00397	CbGeAlD
Nortriptyline—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000839	0.00388	CbGeAlD
Nortriptyline—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000827	0.00382	CbGeAlD
Nortriptyline—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000775	0.00358	CbGeAlD
Nortriptyline—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000746	0.00345	CbGeAlD
Nortriptyline—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000729	0.00337	CbGeAlD
Nortriptyline—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000718	0.00332	CbGeAlD
Nortriptyline—HRH1—brain—amyotrophic lateral sclerosis	0.000709	0.00328	CbGeAlD
Nortriptyline—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000706	0.00326	CbGeAlD
Nortriptyline—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000691	0.00319	CbGeAlD
Nortriptyline—CYP2E1—brain—amyotrophic lateral sclerosis	0.000682	0.00315	CbGeAlD
Nortriptyline—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00068	0.00314	CbGeAlD
Nortriptyline—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000664	0.00307	CbGeAlD
Nortriptyline—PTGS1—brain—amyotrophic lateral sclerosis	0.000657	0.00304	CbGeAlD
Nortriptyline—HTR2A—brain—amyotrophic lateral sclerosis	0.000592	0.00274	CbGeAlD
Nortriptyline—CYP2D6—brain—amyotrophic lateral sclerosis	0.00054	0.00249	CbGeAlD
Nortriptyline—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	2.85e-05	0.000367	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.83e-05	0.000365	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.83e-05	0.000364	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.83e-05	0.000364	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.82e-05	0.000363	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.82e-05	0.000363	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.81e-05	0.000361	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.8e-05	0.000361	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.76e-05	0.000355	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.76e-05	0.000355	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.75e-05	0.000354	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.75e-05	0.000353	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.74e-05	0.000352	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.73e-05	0.000351	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.71e-05	0.000349	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.71e-05	0.000349	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.7e-05	0.000348	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.69e-05	0.000346	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.69e-05	0.000346	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.69e-05	0.000346	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.68e-05	0.000345	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.67e-05	0.000344	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.66e-05	0.000343	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.66e-05	0.000343	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.64e-05	0.000339	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.63e-05	0.000338	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.63e-05	0.000338	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.62e-05	0.000337	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.61e-05	0.000336	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.59e-05	0.000333	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.57e-05	0.000331	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.56e-05	0.000329	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.55e-05	0.000328	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.54e-05	0.000327	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.5e-05	0.000322	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.48e-05	0.000319	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.46e-05	0.000317	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.45e-05	0.000315	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.45e-05	0.000315	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.44e-05	0.000314	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.43e-05	0.000313	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.43e-05	0.000312	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.42e-05	0.000311	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.41e-05	0.000311	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.41e-05	0.000309	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.39e-05	0.000308	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.39e-05	0.000307	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.37e-05	0.000305	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.35e-05	0.000302	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.35e-05	0.000302	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.34e-05	0.000302	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.34e-05	0.000301	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.33e-05	0.0003	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.32e-05	0.000299	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.32e-05	0.000299	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.31e-05	0.000297	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.3e-05	0.000296	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.3e-05	0.000296	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.27e-05	0.000292	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.26e-05	0.000291	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.26e-05	0.00029	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.25e-05	0.00029	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.25e-05	0.000289	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.23e-05	0.000287	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.23e-05	0.000287	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.22e-05	0.000286	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.2e-05	0.000283	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.18e-05	0.00028	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.17e-05	0.000279	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.16e-05	0.000278	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.13e-05	0.000274	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.13e-05	0.000274	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.12e-05	0.000273	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.12e-05	0.000272	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.12e-05	0.000272	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.11e-05	0.000271	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.1e-05	0.000271	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.1e-05	0.00027	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.09e-05	0.000269	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.08e-05	0.000268	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.06e-05	0.000265	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.04e-05	0.000262	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.03e-05	0.000261	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.02e-05	0.00026	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.02e-05	0.00026	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.02e-05	0.000259	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.01e-05	0.000258	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.01e-05	0.000258	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2e-05	0.000257	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.99e-05	0.000256	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.98e-05	0.000255	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.98e-05	0.000255	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.98e-05	0.000255	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.93e-05	0.000249	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.91e-05	0.000246	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.91e-05	0.000246	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.89e-05	0.000244	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.89e-05	0.000243	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.88e-05	0.000242	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.86e-05	0.00024	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.81e-05	0.000233	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	0.000231	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	1.79e-05	0.000231	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.78e-05	0.000229	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.77e-05	0.000228	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.77e-05	0.000228	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.77e-05	0.000228	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.76e-05	0.000227	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.73e-05	0.000223	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.73e-05	0.000223	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.73e-05	0.000223	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.72e-05	0.000222	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.72e-05	0.000221	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.7e-05	0.000219	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.7e-05	0.000218	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.67e-05	0.000215	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.66e-05	0.000214	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.66e-05	0.000213	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.64e-05	0.00021	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.63e-05	0.00021	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.63e-05	0.00021	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.63e-05	0.000209	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.63e-05	0.000209	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000209	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000208	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.6e-05	0.000206	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.6e-05	0.000205	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.59e-05	0.000205	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	1.59e-05	0.000205	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.59e-05	0.000204	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.57e-05	0.000201	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.55e-05	0.0002	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.54e-05	0.000199	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.53e-05	0.000197	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.53e-05	0.000197	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.52e-05	0.000196	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.48e-05	0.00019	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.47e-05	0.000189	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.46e-05	0.000188	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.45e-05	0.000187	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.44e-05	0.000185	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.44e-05	0.000185	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.43e-05	0.000184	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.43e-05	0.000184	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.41e-05	0.000182	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.41e-05	0.000182	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	0.00018	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.37e-05	0.000176	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.36e-05	0.000175	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000173	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000172	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000172	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000172	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.33e-05	0.000172	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.33e-05	0.000172	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.33e-05	0.000171	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000169	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.31e-05	0.000169	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.28e-05	0.000165	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.28e-05	0.000164	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.26e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.26e-05	0.000162	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.26e-05	0.000162	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.26e-05	0.000162	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.00016	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.24e-05	0.00016	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.23e-05	0.000158	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.22e-05	0.000157	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.21e-05	0.000155	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.19e-05	0.000153	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.16e-05	0.000149	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.16e-05	0.000149	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.15e-05	0.000148	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000147	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.14e-05	0.000147	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.13e-05	0.000146	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.13e-05	0.000146	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.13e-05	0.000145	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.11e-05	0.000143	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.11e-05	0.000142	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.1e-05	0.000142	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.1e-05	0.000141	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.09e-05	0.00014	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.09e-05	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.09e-05	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.07e-05	0.000138	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.07e-05	0.000137	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.07e-05	0.000137	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.03e-05	0.000133	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.02e-05	0.000132	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.88e-06	0.000127	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.83e-06	0.000126	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.79e-06	0.000126	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.62e-06	0.000124	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	9.51e-06	0.000122	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	9.43e-06	0.000121	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.41e-06	0.000121	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.33e-06	0.00012	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.29e-06	0.000119	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.18e-06	0.000118	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.16e-06	0.000118	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.89e-06	0.000114	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.67e-06	0.000112	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.55e-06	0.00011	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.53e-06	0.00011	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.51e-06	0.00011	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.49e-06	0.000109	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.46e-06	0.000109	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.38e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.38e-06	0.000108	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.35e-06	0.000108	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.34e-06	0.000107	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.22e-06	0.000106	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.19e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.07e-06	0.000104	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.06e-06	0.000104	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	8.06e-06	0.000104	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.05e-06	0.000104	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.02e-06	0.000103	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.99e-06	0.000103	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.98e-06	0.000103	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.92e-06	0.000102	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.9e-06	0.000102	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.89e-06	0.000102	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.73e-06	9.94e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.56e-06	9.72e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.36e-06	9.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.27e-06	9.35e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.24e-06	9.32e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.22e-06	9.3e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.2e-06	9.27e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.18e-06	9.24e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.11e-06	9.15e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.09e-06	9.12e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.09e-06	9.12e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.52e-06	8.39e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.46e-06	8.31e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.33e-06	8.15e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.3e-06	8.11e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.22e-06	8e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.03e-06	7.76e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.56e-06	7.15e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.52e-06	7.1e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.47e-06	7.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.46e-06	7.02e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.44e-06	7e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.42e-06	6.98e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.37e-06	6.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.36e-06	6.89e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.26e-06	5.48e-05	CbGpPWpGaD
